medroxyprogesterone acetate has been researched along with Carcinoma, Small Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berman, ML; DiSaia, PJ; Mannel, RS; Rettenmaier, MA; Stratton, JA | 1 |
1 other study(ies) available for medroxyprogesterone acetate and Carcinoma, Small Cell
| Article | Year |
|---|---|
Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay.
Topics: Actuarial Analysis; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Subrenal Capsule Assay; Uterine Neoplasms | 1989 |